Mesoblast Ltd. (MESO)
13.80
-0.48
(-3.36%)
USD |
NASDAQ |
Jun 10, 16:00
13.82
+0.02
(+0.11%)
After-Hours: 20:00
Mesoblast Max Drawdown (5Y) : 95.66% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 95.66% |
| April 30, 2026 | 95.66% |
| March 31, 2026 | 95.66% |
| February 28, 2026 | 95.66% |
| January 31, 2026 | 95.66% |
| December 31, 2025 | 95.66% |
| November 30, 2025 | 95.66% |
| October 31, 2025 | 95.66% |
| September 30, 2025 | 95.66% |
| August 31, 2025 | 95.66% |
| July 31, 2025 | 95.66% |
| June 30, 2025 | 95.66% |
| May 31, 2025 | 95.66% |
| April 30, 2025 | 95.66% |
| March 31, 2025 | 95.66% |
| February 28, 2025 | 95.66% |
| January 31, 2025 | 95.66% |
| December 31, 2024 | 95.66% |
| November 30, 2024 | 95.66% |
| October 31, 2024 | 95.66% |
| September 30, 2024 | 95.66% |
| August 31, 2024 | 95.66% |
| July 31, 2024 | 95.66% |
| June 30, 2024 | 95.66% |
| May 31, 2024 | 95.66% |
| Date | Value |
|---|---|
| April 30, 2024 | 95.66% |
| March 31, 2024 | 95.66% |
| February 29, 2024 | 95.66% |
| January 31, 2024 | 95.66% |
| December 31, 2023 | 94.95% |
| November 30, 2023 | 94.19% |
| October 31, 2023 | 94.19% |
| September 30, 2023 | 93.84% |
| August 31, 2023 | 93.79% |
| July 31, 2023 | 88.79% |
| June 30, 2023 | 88.79% |
| May 31, 2023 | 88.79% |
| April 30, 2023 | 88.79% |
| March 31, 2023 | 88.79% |
| February 28, 2023 | 88.79% |
| January 31, 2023 | 88.79% |
| December 31, 2022 | 88.79% |
| November 30, 2022 | 88.79% |
| October 31, 2022 | 88.79% |
| September 30, 2022 | 88.79% |
| August 31, 2022 | 88.79% |
| July 31, 2022 | 88.79% |
| June 30, 2022 | 88.79% |
| May 31, 2022 | 87.21% |
| April 30, 2022 | 87.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Propanc Biopharma, Inc. | 100.0% |
| Telix Pharmaceuticals Ltd. | -- |
| Amplia Therapeutics Ltd. | 99.29% |
| Immutep Ltd. | 94.08% |
| Fate Therapeutics, Inc. | 99.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.36 |
| Beta (5Y) | 2.049 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 99.48% |
| Historical Sharpe Ratio (5Y) | -0.0362 |
| Historical Sortino (5Y) | -0.0822 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.45% |